Relafen 750, structurally known as naproxen , offers a specific metabolic profile of action. From a pharmaceutical angle , it functions primarily as a non-copyrightal compound , inhibiting COX enzymes – specifically COX-1 and COX-2 – to alleviate inflammation and fever . The ensuing decrease in hormone-like substance production impacts a divers